Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2015 1
2016 2
2018 1
2019 1
2020 6
2021 6
2022 11
2023 3
2024 7
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Berenguer-Ruiz S, Aparicio-Domínguez M, Herranz-Pinto P, Ruíz-Villaverde R, López-Ferrer A, Santos-Juanes J, Rodríguez Fernández-Freire L, Hospital-Gil M, Arias-Santiago S, Carretero-Hernández G, Mateu-Puchades A, Ferran M, Del Alcázar E, Santos-Alarcón S, Garcia-Latasa de Aranibar FJ, Belinchón-Romero I, González-Cantero Á, Ruíz-Genao D, Eiris-Salvado N, Rocamora-Durán V, Rivera-Diaz R, de la Cueva P, Daudén E, Salgado-Boquete L, Llamas-Velasco M; Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Berenguer-Ruiz S, et al. Among authors: rodriguez fernandez freire l. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):2517-2525. doi: 10.1111/jdv.19468. Epub 2023 Sep 1. J Eur Acad Dermatol Venereol. 2023. PMID: 37625815
[Update of the topical treatment of psoriasis].
Carrascosa JM, Vanaclocha F, Borrego L, Fernández-López E, Fuertes A, Rodríguez-Fernández-Freire L, Zulaica A, Tuneu A, Caballé G, Colomé E, Bordas X, Hernanz JM, Brufau C, Herrera E. Carrascosa JM, et al. Among authors: rodriguez fernandez freire l. Actas Dermosifiliogr. 2009 Apr;100(3):190-200. Actas Dermosifiliogr. 2009. PMID: 19457304 Spanish.
Tildrakizumab: short-term efficacy and safety in real clinical practice.
Galán-Gutierrez M, Rodriguez-Fernandez Freire L, Ruiz-Villaverde R. Galán-Gutierrez M, et al. Among authors: rodriguez fernandez freire l. Int J Dermatol. 2022 Sep;61(9):e355-e357. doi: 10.1111/ijd.15840. Epub 2021 Oct 11. Int J Dermatol. 2022. PMID: 34632570 No abstract available.
A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study.
Puig L, Izu Belloso R, Rivera-Díaz R, Mollet Sánchez J, Rodríguez Fernández-Freire L, Sahuquillo-Torralba A, Ruiz-Villaverde R; IMPULSE investigators group. Puig L, et al. Among authors: rodriguez fernandez freire l. Dermatology. 2024;240(5-6):778-792. doi: 10.1159/000540019. Epub 2024 Jul 17. Dermatology. 2024. PMID: 39019021 Free PMC article.
Secukinumab: Drug Survival in Clinical Practice Settings.
Ruiz-Villaverde R, Rodríguez Fernández-Freire L, Galán-Gutiérrez M, Armario-Hita JC, Martinez-Pilar L. Ruiz-Villaverde R, et al. Among authors: rodriguez fernandez freire l. Actas Dermosifiliogr (Engl Ed). 2021 Apr;112(4):361-364. doi: 10.1016/j.ad.2019.05.018. Epub 2020 Oct 28. Actas Dermosifiliogr (Engl Ed). 2021. PMID: 33129781 Free article. English, Spanish.
Increasing prevalence of psoriasis in Spain: A population-based study (2018-2022).
Cayuela L, Pereyra-Rodríguez JJ, Hernández-Rodríguez JC, Rodríguez Fernandez-Freire L, Cayuela A. Cayuela L, et al. Among authors: rodriguez fernandez freire l. Med Clin (Barc). 2024 Nov 18:S0025-7753(24)00590-6. doi: 10.1016/j.medcli.2024.08.019. Online ahead of print. Med Clin (Barc). 2024. PMID: 39562231 English, Spanish.
30 results